JP2002521468A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002521468A5 JP2002521468A5 JP2000562338A JP2000562338A JP2002521468A5 JP 2002521468 A5 JP2002521468 A5 JP 2002521468A5 JP 2000562338 A JP2000562338 A JP 2000562338A JP 2000562338 A JP2000562338 A JP 2000562338A JP 2002521468 A5 JP2002521468 A5 JP 2002521468A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- pharmaceutical composition
- embedded image
- composition according
- nitrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229960000325 emedastine Drugs 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 229960000351 terfenadine Drugs 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI001743A IT1303671B1 (it) | 1998-07-28 | 1998-07-28 | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| IT98A001743 | 1998-07-28 | ||
| PCT/EP1999/005171 WO2000006531A2 (en) | 1998-07-28 | 1999-07-20 | Nitric esters and nitrate salts of specific drugs |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002521468A JP2002521468A (ja) | 2002-07-16 |
| JP2002521468A5 true JP2002521468A5 (enExample) | 2006-08-31 |
| JP4455760B2 JP4455760B2 (ja) | 2010-04-21 |
Family
ID=11380535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000562338A Expired - Fee Related JP4455760B2 (ja) | 1998-07-28 | 1999-07-20 | 特定の薬物の硝酸エステル及び硝酸塩 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US6410791B1 (enExample) |
| EP (1) | EP1098870B1 (enExample) |
| JP (1) | JP4455760B2 (enExample) |
| KR (1) | KR100687806B1 (enExample) |
| CN (1) | CN1264828C (enExample) |
| AT (1) | ATE307796T1 (enExample) |
| AU (2) | AU770313C (enExample) |
| BR (1) | BR9912375A (enExample) |
| CA (1) | CA2338854C (enExample) |
| DE (1) | DE69927977T2 (enExample) |
| DK (1) | DK1098870T3 (enExample) |
| ES (1) | ES2252958T3 (enExample) |
| HU (1) | HUP0102706A3 (enExample) |
| IL (1) | IL140685A0 (enExample) |
| IT (1) | IT1303671B1 (enExample) |
| RU (1) | RU2254330C2 (enExample) |
| WO (1) | WO2000006531A2 (enExample) |
| ZA (1) | ZA200100457B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| IT1317735B1 (it) * | 2000-01-26 | 2003-07-15 | Nicox Sa | Sali di agenti antimicrobici. |
| US6642276B2 (en) * | 2001-10-01 | 2003-11-04 | M/S Ind-Swift Limited | Controlled release macrolide pharmaceutical formulations |
| CA2487414A1 (en) | 2002-06-11 | 2003-12-18 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| WO2004002420A2 (en) * | 2002-06-28 | 2004-01-08 | Nitromed, Inc. | Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| GB0406069D0 (en) * | 2004-03-17 | 2004-04-21 | Thompson James | Process |
| RU2008100237A (ru) * | 2005-06-14 | 2009-07-20 | Джилид Сайэнс, Инк. (US) | ОБЩИЕ ПРОЛЕКАРСТВЕННЫЕ ФОРМЫ СТЕРОИДОВ И β-АГОНИСТОВ (ВАРИАНТЫ), ВКЛЮЧАЮЩИЙ ИХ АЭРОЗОЛЬНЫЙ СОСТАВ (ВАРИАНТЫ) И СПОСОБ ПРЕДОТВРАЩЕНИЯ И/ИЛИ ЛЕЧЕНИЯ ЛЕГОЧНЫХ ВОСПАЛЕНИЙ И/ИЛИ БРОНХОСТЕНОЗА С ИХ ПОМОЩЬЮ |
| TW200804241A (en) * | 2006-02-24 | 2008-01-16 | Novartis Ag | New salt |
| JP2007275193A (ja) * | 2006-04-04 | 2007-10-25 | Fujifilm Corp | 光プローブおよび光断層画像化装置 |
| WO2009142772A2 (en) | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| JP6042197B2 (ja) * | 2012-12-11 | 2016-12-14 | エア・ウォーター株式会社 | 肺障害治療剤 |
| CN104211605B (zh) * | 2014-08-18 | 2016-04-27 | 江苏正大清江制药有限公司 | 一种氨溴索与间羟基苯甲酸共晶及其制备方法 |
| CN104211604B (zh) * | 2014-08-18 | 2016-05-11 | 江苏正大清江制药有限公司 | 一种氨溴索与对羟基苯甲酸的共晶及其制备方法 |
| CN109982692A (zh) | 2016-11-14 | 2019-07-05 | 王明武 | 用于治疗眼表疾病的制剂和相关方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2944061A (en) * | 1957-09-20 | 1960-07-05 | Acyl derivatives and process | |
| GB865750A (en) * | 1958-09-26 | 1961-04-19 | American Cyanamid Co | Spiro-phosphonium salts |
| NL285698A (enExample) * | 1961-11-20 | 1900-01-01 | ||
| JPS56113748A (en) * | 1980-02-13 | 1981-09-07 | Kowa Co | Aminoethanol derivative and its preparation |
| DE3124410A1 (de) * | 1981-06-22 | 1983-01-05 | Heinrich Mack Nachf., 7918 Illertissen | Verfahren zur herstellung von isosorbid-2-nitrat |
| US4996061A (en) * | 1987-10-07 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical composition for piperidinoalkanol-decongestant combination |
| GB9001019D0 (en) * | 1990-01-17 | 1990-03-14 | Euro Celtique Sa | Pharmaceutical aerosol |
| US5429825A (en) * | 1992-06-26 | 1995-07-04 | Mcneil-Ppc, Inc. | Rotomelt granulation |
| TW401300B (en) * | 1992-12-25 | 2000-08-11 | Senju Pharma Co | Antiallergic composition for ophthalmic or nasal use |
| BR9407414A (pt) | 1993-09-07 | 1996-11-12 | Procter & Gamble | Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo |
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| CA2184828C (en) * | 1994-03-28 | 2008-08-12 | Shanta M. Modak | Composition for inactivating irritants in fluids |
| WO1995030641A1 (en) * | 1994-05-10 | 1995-11-16 | Nicox S.A. | Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| US6245350B1 (en) * | 1994-12-16 | 2001-06-12 | Warner-Lambert Company | Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process |
| US6469009B1 (en) * | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
| EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
| EP0954327A1 (en) | 1996-06-28 | 1999-11-10 | Oxigene, Inc. | Useful formulations of acid addition salt drugs |
| ID23431A (id) * | 1996-10-31 | 2000-04-20 | Schering Corp | Komposisi-komposisi untuk pengobatan asma yang mengandung loratadin dan suatu dekongestan |
| DE19721467A1 (de) * | 1997-05-22 | 1998-11-26 | Basf Ag | Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe |
| IN188720B (enExample) * | 1997-11-06 | 2002-11-02 | Panacea Biotec Ltd | |
| CN1283115A (zh) | 1997-12-23 | 2001-02-07 | 先灵公司 | 用于治疗呼吸道和皮肤病的含有至少一种白三烯拮抗剂和至少一种抗组胺药的组合物 |
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| IT1308633B1 (it) * | 1999-03-02 | 2002-01-09 | Nicox Sa | Nitrossiderivati. |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311923B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1317735B1 (it) * | 2000-01-26 | 2003-07-15 | Nicox Sa | Sali di agenti antimicrobici. |
| US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| US6479692B1 (en) * | 2001-05-02 | 2002-11-12 | Nobex Corporation | Methods of synthesizing acylanilides including bicalutamide and derivatives thereof |
| ITMI20021392A1 (it) * | 2002-06-25 | 2003-12-29 | Nicox Sa | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
-
1998
- 1998-07-28 IT IT1998MI001743A patent/IT1303671B1/it active
-
1999
- 1999-07-20 BR BR9912375-4A patent/BR9912375A/pt not_active Application Discontinuation
- 1999-07-20 US US09/743,808 patent/US6410791B1/en not_active Expired - Fee Related
- 1999-07-20 WO PCT/EP1999/005171 patent/WO2000006531A2/en not_active Ceased
- 1999-07-20 RU RU2001102262/04A patent/RU2254330C2/ru not_active IP Right Cessation
- 1999-07-20 EP EP99938300A patent/EP1098870B1/en not_active Expired - Lifetime
- 1999-07-20 CN CNB998090425A patent/CN1264828C/zh not_active Expired - Fee Related
- 1999-07-20 JP JP2000562338A patent/JP4455760B2/ja not_active Expired - Fee Related
- 1999-07-20 ES ES99938300T patent/ES2252958T3/es not_active Expired - Lifetime
- 1999-07-20 HU HU0102706A patent/HUP0102706A3/hu unknown
- 1999-07-20 IL IL14068599A patent/IL140685A0/xx not_active IP Right Cessation
- 1999-07-20 KR KR1020017000803A patent/KR100687806B1/ko not_active Expired - Fee Related
- 1999-07-20 AT AT99938300T patent/ATE307796T1/de active
- 1999-07-20 CA CA2338854A patent/CA2338854C/en not_active Expired - Fee Related
- 1999-07-20 AU AU52857/99A patent/AU770313C/en not_active Ceased
- 1999-07-20 DE DE69927977T patent/DE69927977T2/de not_active Expired - Lifetime
- 1999-07-20 DK DK99938300T patent/DK1098870T3/da active
-
2001
- 2001-01-16 ZA ZA200100457A patent/ZA200100457B/en unknown
-
2002
- 2002-05-22 US US10/151,955 patent/US6828342B2/en not_active Expired - Fee Related
-
2003
- 2003-12-17 US US10/736,688 patent/US7122539B2/en not_active Expired - Fee Related
-
2004
- 2004-04-07 AU AU2004201457A patent/AU2004201457A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002521468A5 (enExample) | ||
| CA2540174A1 (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| JP2002517491A5 (enExample) | ||
| BR0214199A (pt) | Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração | |
| DE59509518D1 (de) | Formulierung zur inhalativen applikation | |
| BG106095A (bg) | Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици | |
| EP1428821A8 (en) | Piperidin-4-yl amines with analgesic effect | |
| JP2002524520A5 (enExample) | ||
| MY130803A (en) | New quinuclidine amide derivatives | |
| SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| CA2495275A1 (en) | Aerosol formulation for inhalation comprising an anticholinergic agent | |
| JP2002510633A5 (enExample) | ||
| WO2004000840A3 (en) | Quinuclidine derivatives and pharmaceutical compositions containing the same | |
| JP2006506345A5 (enExample) | ||
| JP2002519425A5 (enExample) | ||
| MA27702A1 (fr) | Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation | |
| WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
| JP2002522501A5 (enExample) | ||
| EP0992509A3 (en) | Novel macrolide derivatives | |
| JP2002506864A5 (enExample) | ||
| WO2002000166A3 (en) | New compounds useful as antibacterial agents | |
| WO2014158119A1 (en) | Aqueous solution composition containing ipratropium and oxymetazoline | |
| JPS62178524A (ja) | 鼻内投与用製剤およびその製造法 |